High dose-rate brachytherapy as a treatment option in primary tracheal tumors
نویسندگان
چکیده
منابع مشابه
High dose-rate brachytherapy as a treatment option in primary tracheal tumors.
PURPOSE To present experience with high dose-rate endobronchial brachytherapy in the treatment of primary tracheal tumors. PATIENTS AND METHODS Four patients with nonresected primary tracheal tumors are presented: 2 cases of squamous cell carcinoma of the trachea, 1 of recurrent adenoid cystic carcinoma, and 1 with recurrent plasmacytoma. All received brachytherapy, alone or as a boost for pr...
متن کاملHigh Dose Rate Brachytherapy as a Treatment Option in Endobronchial Tumors
Purpose. To report our experience with high dose rate endobronchial brachytherapy (HDR-EBBT) and to assess its efficacy and tolerability with possibility of its use in selected cases with curative intent. Method. Retrospective review of patients with endobronchial tumors treated at our institution in 2007-2013 with HDR-EBBT. Subjective response and treatment related toxicity were extracted from...
متن کاملHigh dose rate brachytherapy for nonmalignant airway obstruction: new treatment option.
STUDY OBJECTIVES High dose rate (HDR) endobronchial brachytherapy is widely used as a palliative treatment for symptomatic airway obstruction by primary or secondary malignant tumors. We report on a successful use of HDR brachytherapy in patients with nonmalignant airway obstruction. DESIGN Case series PATIENTS Six patients received HDR brachytherapy for airway obstruction caused by granula...
متن کاملFractionated High-Dose-Rate Brachytherapy
Purpose: A growing body of data suggests that local control in nasopharyngeal cancer (NPC) is related to the radiation dose administered. We conducted a singleinstitution study of high-dose radiotherapy (RT), which incorporated high-dose-rate (HDR) brachytherapy (BT). These results were analyzed together with data obtained from controls who did not receive BT. Patients and Methods: The BT group...
متن کاملHigh-dose-rate brachytherapy – a novel treatment approach for primary clear cell adenocarcinoma of male urethra
The incidence of male urethral cancer is rare with age preponderance of 50 to 60 years. The standard management approach is surgery. Here, we present a novel treatment approach for male urethral cancer. Thirty-six year old male, case of primary clear cell adenocarcinoma of urethra who refused surgery, underwent cystoscopic assisted intraluminal HDR brachytherapy. Patient received a dose of 36 G...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinics
سال: 2005
ISSN: 1807-5932
DOI: 10.1590/s1807-59322005000400007